Efficacy of tacrolimus ointment in the prevention and treatment of contact dermatitis.
Anderson
Bryan E
BE
Marks
James G
JG
Mauger
David T
DT
D016022:Case-Control Studies; D002396:Catechols / Q000009:adverse effects; D017449:Dermatitis, Allergic Contact / Q000188:drug therapy / Q000517:prevention & control; D003877:Dermatitis, Contact / Q000188:drug therapy / Q000517:prevention & control*; D017453:Dermatitis, Irritant / Q000188:drug therapy / Q000517:prevention & control; D011040:Dermatitis, Toxicodendron / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009824:Ointments; D010865:Pilot Projects; D016037:Single-Blind Method; D012967:Sodium Dodecyl Sulfate / Q000009:adverse effects; D013501:Surface-Active Agents / Q000009:adverse effects; D016559:Tacrolimus / Q000627:therapeutic use*; D012251:Toxicodendron / Q000009:adverse effects
D002396:Catechols; D007166:Immunosuppressive Agents; D009824:Ointments; D013501:Surface-Active Agents; D012967:Sodium Dodecyl Sulfate; C003747:urushiol; D016559:Tacrolimus